top of page

Innovative Biotech Solutions

The Science Behind

Our Approach

Rafias’ research builds on over a decade of neuroscience and epigenetics work at the University of Pennsylvania’s Heller Lab. Our studies focus on activating the transcription factor Nr4a1, a key regulator of neural homeostasis, to reverse cocaine-induced changes in the brain and restore recovery pathways.

Morphing Shape_edited.jpg

Nr4a1 suppresses cocaine-induced behavior via epigenetic regulation of homeostatic target genes

Reveals how activating Nr4a1 reduces cocaine-seeking behavior and restores neural homeostasis through epigenetic regulation.

Authors

Carpenter MD, Hu Q, Bond AM, Lombroso SI, Czarnecki KS, Lim CJ, Song H, Wimmer ME, Pierce RC, Heller EA.

 

Journal + Citation

Nature Communications. 2020;11(1):504.

 

Read on PubMed →

Cocaine regulation of Nr4a1 chromatin bivalency and mRNA in male and female mice

Demonstrates sex-specific epigenetic regulation of Nr4a1, offering insights into biological differences in cocaine response.

Authors

Fischer DK, Krick KS, Han C, Woolf MT, Heller EA.


Journal + Citation

Scientific Reports. 2022;12(1):15735.

 

Read on PubMed →

Additional Publications from Heller Lab

Hellerlab Team Photo (1).jpg

Explore the full body of work advancing molecular neuroscience and addiction research. The Heller Lab’s work bridges molecular neuroscience and behavioral research.

Dr. Heller with members of her research lab at the University of Pennsylvania.

bottom of page